WO2008102859A1 - Agent for prevention and/or treatment of anxiety disorders - Google Patents

Agent for prevention and/or treatment of anxiety disorders Download PDF

Info

Publication number
WO2008102859A1
WO2008102859A1 PCT/JP2008/053012 JP2008053012W WO2008102859A1 WO 2008102859 A1 WO2008102859 A1 WO 2008102859A1 JP 2008053012 W JP2008053012 W JP 2008053012W WO 2008102859 A1 WO2008102859 A1 WO 2008102859A1
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
agent
treatment
anxiety disorders
disclosed
Prior art date
Application number
PCT/JP2008/053012
Other languages
French (fr)
Japanese (ja)
Inventor
Koji Teshima
Original Assignee
Mitsubishi Tanabe Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corporation filed Critical Mitsubishi Tanabe Pharma Corporation
Priority to JP2009500240A priority Critical patent/JPWO2008102859A1/en
Publication of WO2008102859A1 publication Critical patent/WO2008102859A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Disclosed is an agent for prevention and/or treatment of anxiety disorders. Specifically disclosed is an agent for prevention and/or treatment of anxiety disorders, which contains a compound represented by the general formula (I) below, a racemic mixture thereof, a corresponding enantiomer of any of them, or a pharmaceutically acceptable salt of any of them as an active ingredient. (In the formula, the symbols are as defined in the description.)
PCT/JP2008/053012 2007-02-22 2008-02-22 Agent for prevention and/or treatment of anxiety disorders WO2008102859A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009500240A JPWO2008102859A1 (en) 2007-02-22 2008-02-22 Drugs for the prevention and / or treatment of anxiety disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007042734 2007-02-22
JP2007-042734 2007-02-22

Publications (1)

Publication Number Publication Date
WO2008102859A1 true WO2008102859A1 (en) 2008-08-28

Family

ID=39710130

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053012 WO2008102859A1 (en) 2007-02-22 2008-02-22 Agent for prevention and/or treatment of anxiety disorders

Country Status (2)

Country Link
JP (1) JPWO2008102859A1 (en)
WO (1) WO2008102859A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345649A1 (en) * 2008-09-16 2011-07-20 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound in crystal form and salt thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082333A1 (en) * 2002-03-29 2003-10-09 Mitsubishi Pharma Corporation Remedy for sleep disturbance
WO2005028466A1 (en) * 2003-09-25 2005-03-31 Solvay Pharmaceuticals B.V. Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082333A1 (en) * 2002-03-29 2003-10-09 Mitsubishi Pharma Corporation Remedy for sleep disturbance
WO2005028466A1 (en) * 2003-09-25 2005-03-31 Solvay Pharmaceuticals B.V. Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345649A1 (en) * 2008-09-16 2011-07-20 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound in crystal form and salt thereof
EP2345649A4 (en) * 2008-09-16 2012-07-04 Mitsubishi Tanabe Pharma Corp Benzimidazole compound in crystal form and salt thereof
US8471032B2 (en) 2008-09-16 2013-06-25 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound in crystal form and salt thereof

Also Published As

Publication number Publication date
JPWO2008102859A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
WO2008005368A3 (en) Piperazines as p2x7 antagonists
WO2005080352A3 (en) Quinazoline derivatives and therapeutic use thereof
WO2007117465A3 (en) Indazole compounds
WO2007084728A3 (en) 2-imino-benzimidazoles
WO2009051119A1 (en) Pyrimidyl indoline compound
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
WO2011058474A8 (en) N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2007136759A3 (en) Method for the treatment and prevention of ocular disorders
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
TW200728307A (en) Novel spirochromanone derivatives
IS2533B (en) (S) -2-N-propylamino-5-hydroxyetraline as D3 agonist
WO2005089753A3 (en) Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders
WO2010066629A3 (en) Novel azaindoles
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
WO2009041663A1 (en) Agent for prevention and/or treatment of skin diseases
RS53613B1 (en) Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
TN2012000092A1 (en) Therapeutic agent for mood disorders
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
WO2008131946A3 (en) Substituted amide derivatives
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
WO2009051223A1 (en) Pharmaceutical composition for treatment of cataract
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711786

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009500240

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08711786

Country of ref document: EP

Kind code of ref document: A1